FDA Inspection
New Direction Biosciences LLCNew Direction Biosciences LLC – FDA Inspection, Jun 12, 2015
Record Details
This FDA Inspection record concerns New Direction Biosciences LLC, with an inspection on June 12, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 12, 2015
- Product Type
- Biologics
View Company Profile
ID · ef93050a-2880-48e8-a984-654b62f2d981
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 931321
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
9- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.84(a)Components withheld from use pending release
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 1271.150(c)(1)(iii)Ensurane of compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New Direction Biosciences LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2013 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 12, 2011 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for New Direction Biosciences LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.